OpenVSafe by OpenVAERS
Search V-safe

48H-22246-68954

3 vaccinations 9 coded responses 25 check-ins 9 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
333 / FL
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-19
    Registered in v-safe
  3. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-19
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work
    Free text: Lymph nodes enlarged and tender
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Enlarged supraclavicular lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Enlarged lymph nodes, on side where vaccine given, axilla and supraclavicular (one is > 1.5 cm)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Enlarged lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-28
    Survey response — day 7, dose 2
    MedDRA: Heavy menstrual bleeding, Lymphadenopathy — Feeling: Fair
    Free text: Heavier than usual period, also still have enlarged supraclavicular lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-11-13
    Dose 3 — Pfizer-BioNTech
  18. 2021-11-13
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-11-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  20. 2021-11-15
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymph node enlarged
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-11-16
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymph node very swollen
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-11-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymph node swollen
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-11-20
    Survey response — day 7, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymph node enlarged
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-12-04
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-12-11
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-12-20
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-25
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-02-14
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-11-13
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Pfizer-BioNTech
22021-01-19Pfizer-BioNTech
32021-11-13Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Lymph nodes enlarged and tender

2021-01-21

Systemic reaction (other): Enlarged supraclavicular lymph node

2021-01-22

Systemic reaction (other): Enlarged lymph nodes, on side where vaccine given, axilla and supraclavicular (one is > 1.5 cm)

2021-01-24

Systemic reaction (other): Enlarged lymph node

Release 2 — day 7, dose 2

2021-01-28

Systemic reaction (other): Heavier than usual period, also still have enlarged supraclavicular lymph node

Release 10 — days 1–6 daily, dose 3

2021-11-15

Systemic reaction (other): Lymph node enlarged

2021-11-16

Systemic reaction (other): Lymph node very swollen

2021-11-18

Systemic reaction (other): Lymph node swollen

Release 10 — day 7, dose 3

2021-11-20

Systemic reaction (other): Lymph node enlarged

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROHeavy menstrual bleeding ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…